Jean-Pierre Sommadossi insider trades: Atea Pharmaceuticals (AVIR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jean-Pierre reports to the SEC




Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 19, 2024 | AVIR | ↓ Sell | 57,969 | $4.04 | $234K | Held by JPM Partners LLC | Sep 19, 2024 (0d) |
| Jun 5, 2024 | AVIR | ↓ Sell | 1,006 | $4.00 | $4K | Held by JPM Partners LLC | Jun 7, 2024 (2d) |
| Feb 1, 2024 | AVIR | ↓ Sell10b5-1 | 56,910 | $3.85 | $219K | Direct | Feb 2, 2024 (1d) |
| May 9, 2006 | IDIX | ↑ Buy | 10,000 | $9.13 | $91K | Direct | May 11, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AVIR insiders
Open-market trades in the last 12 months
About Jean-Pierre Sommadossi's insider trades
Jean-Pierre Sommadossi is President, CEO, and Chairman at Atea Pharmaceuticals (AVIR). Since May 9, 2006, Jean-Pierre has reported 1 open-market purchase worth $91K and 3 sales worth $457K on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (48% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (15 filings), option exercises (3 filings), shares withheld for taxes (2 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.